Astera Labs (NASDAQ:ALAB) Trading 4.4% Higher on Analyst Upgrade

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price traded up 4.4% on Wednesday after Citigroup raised their price target on the stock from $160.00 to $275.00. Citigroup currently has a buy rating on the stock. Astera Labs traded as high as $252.60 and last traded at $249.38. 5,674,589 shares were traded during mid-day trading, an increase of 14% from the average session volume of 4,960,287 shares. The stock had previously closed at $238.79.

Several other equities analysts also recently commented on ALAB. William Blair began coverage on Astera Labs in a research report on Thursday, May 22nd. They issued an “outperform” rating for the company. CICC Research began coverage on Astera Labs in a research report on Friday, August 29th. They issued an “outperform” rating and a $190.00 target price for the company. Susquehanna increased their target price on Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research report on Thursday, August 7th. Wall Street Zen upgraded Astera Labs from a “hold” rating to a “buy” rating in a research report on Saturday, August 16th. Finally, Evercore ISI increased their target price on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $152.94.

Insider Transactions at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $188.70, for a total value of $1,887,000.00. Following the completion of the sale, the general counsel owned 161,573 shares of the company’s stock, valued at approximately $30,488,825.10. This trade represents a 5.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director directly owned 385,863 shares of the company’s stock, valued at $66,858,482.01. This trade represents a 32.17% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,649,606 shares of company stock valued at $246,588,601. Company insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of ALAB. Oliver Lagore Vanvalin Investment Group purchased a new position in shares of Astera Labs during the second quarter valued at approximately $29,000. Bernard Wealth Management Corp. purchased a new position in shares of Astera Labs during the second quarter valued at approximately $36,000. Clearstead Trust LLC boosted its position in shares of Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after buying an additional 461 shares during the last quarter. Advisors Asset Management Inc. boosted its position in shares of Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after buying an additional 194 shares during the last quarter. Finally, Manchester Capital Management LLC boosted its position in shares of Astera Labs by 141.5% during the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after buying an additional 283 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Up 4.4%

The company has a market cap of $41.45 billion, a PE ratio of 445.32, a PEG ratio of 6.06 and a beta of 1.48. The company has a 50-day moving average of $163.87 and a 200-day moving average of $107.03.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million for the quarter, compared to analysts’ expectations of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs’s quarterly revenue was up 149.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.